Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 3,176 | 2,022 | 2,874 | 1,300 | 3,965 |
| Cost of Goods | 125 | 22 | 141 | 51 | 8 |
| Gross Profit | 3,051 | 2,000 | 2,733 | 1,249 | 3,957 |
| Operating Expenses | 16,007 | 11,335 | 9,500 | 26,067 | 5,824 |
| Operating Income | -12,831 | -9,313 | -6,626 | -24,767 | -1,859 |
| Interest Expense | 182 | 170 | 124 | 36 | 5 |
| Other Income | -307 | 15,952 | 101 | 46 | -4 |
| Pre-tax Income | -13,320 | 6,469 | -6,649 | -24,757 | -1,868 |
| Income Tax | -103 | 719 | -33 | -715 | -4 |
| Net Income Continuous | -13,217 | 5,750 | -6,616 | -24,042 | -1,864 |
| Net Income | $-13,217 | $5,750 | $-6,616 | $-24,042 | $-1,864 |
| EPS Basic Total Ops | -0.38 | 0.16 | -0.19 | -0.70 | -0.05 |
| EPS Basic Continuous Ops | -0.38 | 0.17 | -0.19 | -0.70 | -0.05 |
| EPS Diluted Total Ops | -0.38 | 0.16 | -0.19 | -0.70 | -0.05 |
| EPS Diluted Continuous Ops | -0.38 | 0.17 | -0.19 | -0.70 | -0.05 |
| EBITDA(a) | $-12,752 | $-9,013 | $-6,228 | $-24,586 | $-1,794 |